Labatec Pharma SA
🇨🇭Switzerland
- Country
- 🇨🇭Switzerland
- Ownership
- Private
- Established
- 1957-01-01
- Employees
- 101
- Market Cap
- -
- Website
- http://www.labatecpharma.com
Effect of Alendronate 70mg Formulation on Bone Turnover Markers and Patient Reported Outcomes
- Conditions
- Osteoporosis, Postmenopausal
- Interventions
- First Posted Date
- 2018-02-15
- Last Posted Date
- 2020-12-03
- Lead Sponsor
- Labatec Pharma SA
- Target Recruit Count
- 80
- Registration Number
- NCT03435094
- Locations
- 🇨🇭
Endokrinologische Praxis & Labor, Basel, BS, Switzerland
🇨🇭Hôpital Universitaire de Genève, Service des maladies osseuses, Genève, GE, Switzerland
© Copyright 2025. All Rights Reserved by MedPath